| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.045 | 0.8 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |